Biontech is currently submitting the last documents to the EMA.
(Photo: dpa)
Dusseldorf Biontech expects its corona variant vaccine to be approved in the coming week and then delivered quickly. “We can deliver very promptly, hopefully from the beginning of September,” said Biontech boss Ugur Sahin in a previously published interview with “Spiegel”.
First he expects the approval of the vaccine based on the original omicron subtype BA.1. But there is also a booster for the BA.5 subtype, which is now dominant. This should only be approved a little later. Biontech is currently submitting the last documents to the EMA. “Then things can also happen quickly here,” said Sahin.
The European Medicines Agency (EMA) recently announced a special meeting for September 1st to discuss applications for booster vaccinations against the omicron variant of the virus. In addition to Biontech/Pfizer, Moderna also wants to bring the corresponding funds onto the market. Great Britain became the first country to approve the corresponding Moderna vaccine in the middle of the month.